Pharmacies - G20

  • G20
  • The projected revenue in the Pharmacies market for the G20 countries is expected to reach a staggering US$1.26tn in 2024.
  • This indicates a significant growth potential in the coming years.
  • Moreover, the market is anticipated to exhibit a steady annual growth rate of 4.11% between 2024 and 2028.
  • By the end of 2028, the market volume is projected to reach an impressive US$1.48tn.
  • When comparing the global market, it is noteworthy that United States is expected to generate the highest revenue in the Pharmacies market sector.
  • In 2024 alone, United States is projected to generate US$387.30bn in revenue.
  • This highlights the dominance of the US market in this market.
  • To put these numbers into perspective, in 2024, the per person revenue generated in the Pharmacies market for the G20 countries is estimated to be US$252.60.
  • This figure indicates the average revenue generated per individual in relation to the total population.
  • It demonstrates the significant economic impact and importance of the Pharmacies market on a per capita basis.
  • In the United States, pharmacies have seen a surge in demand for telepharmacy services during the COVID-19 pandemic.

Key regions: United States, China, Germany, Japan, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Pharmacies market in G20 is experiencing significant growth and development due to various factors. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors all contribute to the expansion of the Pharmacies market in G20.

Customer preferences:
Customers in the G20 countries are increasingly prioritizing convenience and accessibility when it comes to healthcare services. Pharmacies offer a one-stop solution for various healthcare needs, including prescription medications, over-the-counter drugs, and health and wellness products. With the busy lifestyles of consumers in G20 countries, the convenience of being able to access these products and services in one location is highly appealing. Additionally, customers are also seeking personalized and expert advice from pharmacists, who play a crucial role in providing healthcare guidance and recommendations.

Trends in the market:
One of the key trends in the Pharmacies market in G20 is the increasing focus on e-commerce and online pharmacy platforms. With the rise of digitalization and the growing popularity of online shopping, customers are now able to purchase medications and healthcare products online, with the added convenience of doorstep delivery. This trend is particularly prominent in countries with high internet penetration rates and advanced logistics infrastructure. Furthermore, the COVID-19 pandemic has accelerated the adoption of online pharmacy services, as customers seek to minimize physical contact and avoid crowded spaces.

Local special circumstances:
Each country within the G20 has its own unique set of circumstances that impact the Pharmacies market. For example, in countries with aging populations, there is a higher demand for medications and healthcare products, leading to a larger market size. Additionally, countries with universal healthcare systems may have different regulations and reimbursement policies that affect the operations and profitability of pharmacies. Cultural factors and traditional medicine practices also play a role in shaping customer preferences and the types of products and services offered by pharmacies.

Underlying macroeconomic factors:
The overall economic growth and development of the G20 countries have a direct impact on the Pharmacies market. As disposable incomes rise, consumers have more purchasing power and are willing to spend on healthcare products and services. Furthermore, advancements in healthcare technologies and research contribute to the development of new and innovative medications, which in turn drive the growth of the Pharmacies market. Government policies and regulations, such as price controls and intellectual property rights, also influence the market dynamics and competitiveness of pharmacies in the G20 countries. In conclusion, the Pharmacies market in G20 is experiencing growth and development driven by customer preferences for convenience and accessibility, trends in e-commerce and online pharmacy platforms, local special circumstances, and underlying macroeconomic factors. As the healthcare landscape continues to evolve, pharmacies will play a crucial role in meeting the diverse healthcare needs of customers in the G20 countries.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Users
  • Volume
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)